
About


CMS Issues CY2025 Medicare Advantage and Part D Final Rule

Recent Healthcare-Related Artificial Intelligence Developments

2024 Top-of-Mind Issues for Life Sciences Companies

2024 Top-of-Mind Issues for Life Sciences Companies

FDA Issues Final Rule and Guidance on Direct-To-Consumer Prescription Drug Advertisements

CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule

CMS Promotes Competition, Transparency, Health Equity and More in the CY2025 Medicare Advantage and Part D Proposed Rule

From Good Reprint Practices to SIUU Communications: What Firms Need to Know
